Careful classification of potential bedaquiline resistance mutations is critical when analysing their clinical impact

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The international journal of tuberculosis and lung disease 2024-06, Vol.28 (6), p.312-313
Hauptverfasser:	Phelan, J.E., Utpatel, C., Ismail, N., Cortes, T., Niemann, S., Cirillo, D.M., Schön, T., Miotto, P., Köser, C.U.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimicrobial Susceptibility Testing Antitubercular Agents - pharmacology Bdq Diarylquinolines - pharmacology Drug Resistance, Bacterial - genetics Humans Impact analysis Mutation Mycobacterium Tuberculosis Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - isolation & purification Tuberculosis, Multidrug-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!